Worldwide Clinical Trials
Ellen Polokoff is a seasoned medical professional currently serving as the Senior Medical Director of Medical Affairs in Oncology at Worldwide Clinical Trials since February 2023. Polokoff's extensive background includes a leadership role as Senior Attending Physician at Trinity Health of New England Medical Group, where responsibilities centered on advancing breast care practices from 2015 to February 2023. Previous positions include Chief of Staff at Saint Mary's Hospital and Founding Medical Director of The Breast Center at St. Mary's Hospital, where pioneering efforts led to improved breast cancer care. Polokoff founded and owned Polokoff Breast Care from 2007 to 2015, establishing a successful clinical practice, and worked as Partner and Chief Compliance Officer at Surgical Associates-New Haven. Educational achievements include a Doctor of Medicine from New York Medical College and ongoing specializations at The Johns Hopkins University, demonstrating a commitment to continuous professional development in clinical trials and leadership.
This person is not in any teams
This person is not in any offices
Worldwide Clinical Trials
11 followers
About Worldwide Clinical Trials Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that works in partnership with biotechnology and pharmaceutical companies to create customized solutions that advance new treatments. Our capabilities include bioanalytical laboratory services, Phase I-IV clinical trials, and post-approval and real-world evidence studies – all powered by our team members who bring their expertise and a collaborative, personalized approach to each clinical program. Anchored in our company’s scientific heritage, our dedicated therapeutic focus on cardiovascular, metabolic, neuroscience, oncology, and rare diseases, is applied to develop flexible plans and solve problems quickly for our customers. Our talented team of 3,000+ professionals spans 60+ countries, and embraces a culture of diversity, equity, inclusion, and belonging (DEI&B). We are united in cause with our customers to improve the lives of patients through new, innovative therapies. For more information on Worldwide, visit www.Worldwide.com.